 |
Zea Borok, MD
Professor of Medicine, Biochemistry, and Molecular Biology, Dr. Borok is also Chief of Division of Pulmonary and Critical Care Medicine, Associate Director of the Will Rogers Institute Pulmonary Research Center and Director of the Pulmonary and Critical Care Fellowship Training Program at the University of Southern California. |
 |
Harold A. Chapman, Jr, MD
An expert in pulmonary medicine and research, Dr. Chapman serves as chief of the Pulmonary Division at UCSF. He also serves on numerous editorial and advisory boards at UCSF and holds the position of Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at UCSF. |
 |
Augustine MK Choi, MD
The point person for the CIMIT Inhalation Technology Program, Dr. Choi is Chief, Pulmonary and Critical Care Medicine at Brigham and Women's Hospital. Previously he was at the University of Pittsburgh, Yale, and Johns Hopkins. His lab has made seminal observations that inhaled CO can confer cytoprotection in preclinical models of lung diseases. |
 |
Gregory P. Downey, MD
Dr. Downey is the Executive Vice President and Academic Affairs Professor in the departments of Pediatrics and Integrated Department of Immunology at the National Jewish Health & University of Colorado Denver. In 2006 he received the Canadian Cystic Fibrosis Foundation Zeller’s Senior Scientist Award for outstanding contributions to CF Research. |
 |
Jack A. Elias, MD
Dr. Elias is Chairman of the Department of Internal Medicine as well as the Waldemar Von Zedtwitz Professor of Medicine Chief, Beeson Medical Service at Yale-New Haven Hospital. His clinical interests include asthma, COPD, interstitial lung disease and acute lung injury. |
 |
Patricia W. Finn, MD
Dr. Patricia Finn is the Chairman of the Department of Medicine at the University of Illinois Hospital in Chicago. With her new position, she strives to continue the department's commitment to providing exceptional health care and strengthen its scientific investigations by incorporating new technology and medical bioinformatics. Dr. Finn is the current Vice President of ATS and will become President in 2013. |
 |
Paul S. Foster, PhD
Dr. Foster is Professor of Immunology and Microbiology at the University of Newcastle School of Biomedical Sciences and Pharmacy. |
 |
Stella Kourembanas, MD
Dr. Stella Kourembanas is the Clement A. Smith Professor of Pediatrics at Harvard Medical School, chief of the Division of Newborn Medicine at Children's Hospital Boston, and chair of the Harvard Program in Neonatology. She and colleagues are working to elucidate the vascular responses to hypoxia at the molecular, cellular, and organismal levels and to investigate stem cell-based therapeutic approaches for development and vascular diseases of the lung. Dr. Kourembanas joined the ATS in 2001. |
 |
Geoffrey Laurent, PhD
Dr. Laurent is the Director of the Centre for Respiratory Research at University College London where he directs a team of scientists and physicians conducting research into basic aspects of the mechanisms of inflammation and remodelling, as well as programmes in translational research leading to clinical trials in collaboration with industry. He has published over 200 articles and was recently awarded the European Respiratory Societies Presidential Award for his contribution to lung science. He is the Editor-in-Chief of the International Journal of Biochemistry and Cell Biology, and has edited several books including a four volume Encyclopedia of Respiratory Medicine. In June 2006 he was appointed a Fellow of the Academy of Medical Sciences. He was appointed Director of the European Respiratory Society Lung Science Conference in August 2006 and is the President of the British Association for Lung Research. |
 |
George D. Leikauf, PhD
Dr. Leikauf is Professor in Environmental Health at the University of Pittsburgh. His studies focus on the functional genomics of acute lung injury, asthma, and chronic obstructive pulmonary disease. |
 |
Mitchell Olman, MD
Dr. Mitchell Olman is a Full Staff in the Department of Pathobiology and Respiratory Institute at the Cleveland Clinic Lerner Research Institute where he investigates the mechanisms of fibrosis in the lung. His work focuses on mechanisms of cell migration, and on mechanisms and clinical trials of anticoagulants in fibrosis. Previously, he was Professor of Medicine and Pathology at the University of Alabama. |
 |
William C. Parks, PhD
Professor of Medicine and Director of the Center for Lung Biology at the University of Washington, Seattle, Dr. Parks' research focuses on the function of matrix metalloproteinase in immunity and inflammation, with an emphasis on how these enzymes shape the recruitment and activation status of neutrophils and macrophages, and on the molecular regulation of elastin production during development and disease. Among his current national responsibilities, he is President of the American Society for Matrix Biology, a standing member of the NIH Lung Injury, Repair, and Regeneration study section, and on the Advisory Board for the Shriner’s Hospitals Research program. |
 |
Mark A. Perrella, MD
Associate Professor of Medicine at Harvard Medical School and an Associate Physician in the Pulmonary and Critical Care Division at Brigham and Women’s Hospital in Boston, MA, Dr. Perrella has received a number of honors and awards throughout his career including the Internal Medicine Outstanding Achievement Award at the Mayo Graduate School of Medicine; Mayo Foundation Scholar in the Division of Thoracic Diseases and Internal Medicine; Mayo Alumni Association’s Donald C. Balfour Award for Meritorious Research; and the Mayo Foundation Clinician Scholar Award. |
 |
Reynold A. Panettieri, MD
Dr. Panettieri is the Robert L. Mayock and David A. Cooper Professor of Medicine at the University of Pennsylvania. He has conducted clinical research in the area of airway remodeling and irreversible airflow obstruction and disease management of asthma and chronic obstructive pulmonary disease. He is a member of the American Society for Clinical Investigation and the Association of American Physicians. |
 |
Loretta Que, MD
Dr. Que is an Associate Professor of Medicine at Duke University School of Medicine. Her clinical interests include asthma, COPD, and critical care medicine. Her research focuses on understanding the complex interaction between S-nitrosothiol metabolism and host immunological/airway response.
|
 |
J. Usha Raj, MD
Dr. J. Usha Raj is the Physician-in-Chief of the Children’s Hospital University of Illinois (CHUI), a hospital within the University of Illinois Hospital and Health Sciences System. She is also the Professor and Head of the Department of Pediatrics, within the College of Medicine, University of Illinois at Chicago. Previous to this position, she was a Professor at UCLA and the Chief of the Division of Neonatology at Harbor-UCLA Medical Center. She is a nationally and internationally known neonatologist and a physician-scientist, whose research in neonatal pulmonary hypertension has been funded by the National Institutes of Health for over 26 years. She is a member of many national scientific societies and professional associations in which she holds leadership positions. |
 |
David A. Schwartz, MD
Professor of Medicine, Immunology, and Pediatrics, Dr. Schwartz is internationally recognized for his contributions in environmental and occupational lung disease. Dr. Schwartz serves as Director of the Pulmonary Division and Center for Genetics and Therapeutics at NJH. in 2008, Dr. Schwartz served as Director of the NIEHS and the NTP at the NIH between 2005 and 2008. During his tenure at the NIH, he developed the Genes, Environment and Health Initiative, the Epigenomics and Human Health Roadmap Initiative, and a program in translational research in environmental sciences. |
 |
Steven D. Shapiro, MD
Dr. Shapiro is the Jack D. Myers Professor at the University of Pittsburgh and Chairman of the Department of Medicine. His scientific career has focused on understanding the biological functions of matrix degrading proteinases in general and COPD in particular. |
|
Hajime Takizawa, MD, PhD
Professor at Teikyo University, School of Medicine, Tokyo, Japan. |
 |
Judith Voynow, MD
Dr. Voynow is Associate Professor of Pediatric Pulmonology at Duke University, Durham, NC. Her research interest is primarily in regulation of mucin gene expression and regulation in cystic fibrosis and other chronic lung diseases such as COPD, areas within which she has published extensively. She has received several NIH grants including two RO1 grants, a Physician-Scientist grant and serves as a member of the NIH grant review panel. Furthermore, she is a recipient of the prestigious Cystic Fibrosis Foundation’s New Investigator award, NIH First Award, and Children’s Miracle Network award. |
 |
David S. Wilkes, MD
Dr. Wilkes is the Director of the Center for Immunobiology at the Indiana University School of Medicine. He served on the Board of Directors for the American Thoracic Society from 2005-2007 and serves as member of the National Advisory Council of the National Institutes of Allergy and Infectious Diseases at NIH. He served as co-chair for the Workshop on Lung Transplantation: Opportunities for Research and Clinical Advancement, National Heart Lung and Blood Institute, Division of Lung Diseases. His research focuses on the mechanisms of rejection in lung transplantation. |
 |
Guy A. Zimmerman, MD
Dr. Zimmerman is Professor in the Department of Internal Medicine at the University of Utah and a member of the Cell Response and Regulation Program. He studies fundamental mechanisms of infectious, inflammatory, and thrombotic disease, which is relevant to cancer, its complications, and its treatment. He also studies a previously unrecognized protein that contributes to Trousseau’s syndrome and other thrombotic complications of cancer. |
